Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 3/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | DDX3X | O00571 | 1/20 | 0.56 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10517748 | 1.00 | HPGD (1.00) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| Butanedione SCHEMBL28072236 | 0.96 | HPGD (0.92) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| Acetic Acid SCHEMBL28756539 | 0.96 | HPGD (0.92) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| Sulfamide SCHEMBL10380477 | 0.90 | HPGD (0.81) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| Sulfuric Acid SCHEMBL28756598 | 0.89 | HPGD (0.79) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| SCHEMBL28472793 | 0.88 | HPGD (0.78) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| Acetic Acid SCHEMBL28756562 | 0.86 | HPGD (0.73) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| SCHEMBL6689158 | 0.85 | ALDH1A1 (0.74) | HPGDALDH1A1NPC1RAB9APOLB | |
| Butyric Acid SCHEMBL10750853 | 0.84 | HPGD (0.71) | HPGDALDH1A1NPC1RAB9AEPHX1 | |
| SCHEMBL1275926 | 0.84 | RAB9A (0.75) | HPGDALDH1A1NPC1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 837 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122025690-A | Composite modified material of high-toughness graphite bipolar plate and preparation method thereof | 青岛高等密封制品有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119612507-A | Preparation method and application of flexible graphite | 滨州双峰石墨密封材料有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-20250002447-A1 | METHOD FOR PREPARING 2-AMINO-5-CHLORO-N,3-DIMETHYLBENZAMIDE | HUBEI KECY CHEMICAL CO., LTD. (CN) | 2025-01-02 | — | — | US | claimed |
| CN-117623967-A | Preparation method of telmisartan intermediate 3-methyl-4-aminobenzoic acid | 迪嘉药业集团股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116987002-A | Preparation method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 湖北可赛化工有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-115818959-A | Method for reducing cost of glazing isolation glaze | 广西蒙娜丽莎新材料有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115449498-B | Stenotrophomonas, microbial inoculum and method and treatment system for degrading aromatic amine wastewater by using stenotrophomonas and microbial inoculum | 江苏聚庚科技股份有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-114195553-B | Preparation method of fibrous nano-alumina modified ceramic glazed tile | 广西蒙娜丽莎新材料有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-115125536-A | Liquid composition and etching method using the same | 三菱瓦斯化学株式会社 | 2022-09-30 | — | — | CN | claimed |
| CN-114195553-A | Preparation method of fibrous nano-alumina modified ceramic glazed tile | 广西蒙娜丽莎新材料有限公司 | 2022-03-18 | — | — | CN | claimed |
| JP-H08504798-A | — | — | 1996-05-21 | — | — | JP | claimed |
| EP-0674627-A1 | PYRIMIDINE, PYRIDINE, PTERIDINONE AND INDAZOLE DERIVATIVES AS ENZYME INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-10-04 | — | — | EP | claimed |
| EP-0613618-A1 | Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds | AMERICAN CYANAMID COMPANY (US) | 1994-09-07 | — | — | EP | claimed |
| WO-1994014780-A1 | PYRIMIDINE, PYRIDINE, PTERIDINONE AND INDAZOLE DERIVATIVES AS ENZYME INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-07-07 | — | — | WO | claimed |
| EP-0230871-B1 | HALOACYL 1-SUBSTITUTED-1,2,3,4-TETRAHYDROISOQUINOLINES AS HERBICIDE ANTIDOTES | Monsanto Company (US) | 1993-09-22 | — | — | EP | claimed |
| EP-0531271-A1 | Safening herbicidal pyrazolysulfonylureas | MONSANTO COMPANY (US) | 1993-03-10 | — | — | EP | claimed |
| EP-0053890-B1 | PRODUCTION OF ARYL ACYLAMIDASES | The Public Health Laboratory Service Board (GB) | 1985-02-13 | — | — | EP | claimed |
| US-4430433-A | CULTURES, PSEUDOMONAS, HYDROLYSIS OF N-ACETYL-4-HYDROXYANILINE TO 4-HYDROXYANILINE | PUBLIC HEALTH LABORATORY SERVICE BOARD (GB) | 1984-02-07 | — | — | US | claimed |
| US-4123607-A | BACTERICIDES | AMERICAN CYANAMID COMPANY (US) | 1978-10-31 | — | — | US | claimed |
| US-4096333-A | NITROSATION OF A 2-METHYLACETANILIDE | TENNECO CHEMICALS, INC. (US) | 1978-06-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002447-A1 | METHOD FOR PREPARING 2-AMINO-5-CHLORO-N,3-DIMETHYLBENZAMIDE | HNMT, CA3, NAAA | HPGD 848/4885ALDH1A1 1599/4885NPC1 4844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.